Immunity:复旦中山医院武多娇副研究员发表Ⅰ型干扰素的免疫代谢作用

2016-06-29 MedSci MedSci原创

2016年6月21日,国际免疫学权威刊物《Immunity》在线发表了复旦大学附属中山医院武多娇副研究员为第一作者的一篇研究论文,研究发现Ⅰ型干扰素(IFNs)可促进浆细胞样树突状细胞(pDCs)的脂肪酸氧化(FAO)增强,这一作用是支持pDCs快速激活及发挥分泌功能的关键;而且该代谢调节作用是Ⅰ型IFNs发挥免疫功能抑制病毒复制的重要机制之一。该论文被置于Immunity杂志网站首页推荐并配有行

2016621日,国际免疫学权威刊物Immunity在线发表了复旦大学附属中山医院武多娇副研究员为第一作者的一篇研究论文,研究发现Ⅰ型干扰素(IFNs)可促进浆细胞样树突状细胞(pDCs)的脂肪酸氧化(FAO)增强,这一作用是支持pDCs快速激活及发挥分泌功能的关键;而且该代谢调节作用是Ⅰ型IFNs发挥免疫功能抑制病毒复制的重要机制之一。该论文被置于Immunity杂志网站首页推荐并配有行业专家评述。


(图中上左一为武多娇副研究员)

IFNs是一组机体宿主细胞应答病毒、细菌、寄生虫及肿瘤细胞等感染或刺激,分泌的重要的具有多种功能的细胞因子。它们具有广谱抗病毒,调节细胞生长分化及免疫功能等多种生物活性。IFNs家族主要包括三类—Ⅰ型干扰素;其中IFNs(主要是IFNαIFNβ)具有突出的抗病毒感染和免疫调节作用,因此备受关注。

免疫代谢(immunemetabolism)是近5年新兴的领域,人们认识到细胞外信号诱导免疫细胞成熟的关键步骤就是它们细胞代谢的重组。细胞代谢重组(metabolic reprogramming)是免疫细胞执行特定功能的基础,调控细胞代谢是机体固有性和适应性免疫反应的重要机制之一。免疫细胞通常缺乏营养储备,而对于各种生物来说,免疫系统持续感应和应对外界环境的威胁,这是一个巨大的需求和消耗能量的过程。例如,固有免疫细胞或者适应性免疫细胞激活后可分泌大量细胞因子、趋化因子、炎症介质;这些免疫应答只能依赖于免疫细胞从微环境中快速吸收和利用糖、氨基酸和脂肪酸;同时,代谢中间产物参与组蛋白化学修饰,改变染色质构象,发挥转录调节作用。

浆细胞样树突状细胞(pDCs)是一类以大量分泌Ⅰ型IFNs为突出特征的树突状细胞亚群,它的细胞形态、功能与GM-CSF诱导分化的DCs或传统DCscDCs)相比有显著差异,在机体抵御病毒感染中起到重要作用。武博士及同事发现Ⅰ型IFNs具有诱导细胞代谢重组的功能。该研究发现伴随pDCs活化,pDCsFAO水平显著增强。细胞能量代谢实时监测发现,活化的细胞中反映FAO的指标耗氧率(OCR)和呼吸储备能力(SRC)明显升高;而阻断FAO通路可显著抑制pDCs分泌细胞因子以及细胞表面共刺激分子的表达,同时抑制细胞活化伴随升高的脂肪酸氧化水平。

IFNs通过诱导细胞表达多种蛋白质而发挥生物学功能,表达这些功能蛋白质的基因称作干扰素刺激基因(ISGs)。武博士及同事应用IFNAR基因敲除小鼠及RNAseq技术检测分析发现IIFNs通过IIFNs受体介导自分泌信号促进pDCsFAOOXPHOSISGs中有大量的代谢调节相关基因参与了Ⅰ型IFNs介导的细胞代谢重组作用。该研究在体内淋巴细胞脉络丛脑膜炎病毒(LCMV)感染的小鼠模型中发现抑制FAO将促进LCMV病毒复制,说明Ⅰ型IFNs促进LCMV感染小鼠体内能量分解代谢,竞争性抑制病毒复制活动,是其发挥抗病毒感染的重要机制之一。


杂志社在发表该研究成果时,配发l篇评述“pDCs Take a Deep Breath to Fight Viruses”。该评述指出深入理解免疫代谢调控机制可为我们提供防治疾病新的视野和手段。Ⅰ型IFNs为重要的抗感染、肿瘤或者炎症的细胞因子,具有复杂的免疫调节功能。免疫系统抵御病原微生物保持机体内环境稳态。这些功能需要足够的能量支持及精准细胞代谢通路的控制。此研究从免疫代谢角度阐明Ⅰ型IFNs新的抗病毒机制;并且也通过解析Ⅰ型IFNs对于靶细胞的免疫代谢调节分子机制,揭示操纵免疫代谢途径的可能性。

原始出处:

Wu D, Sanin DE,et al.Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function.Immunity. 2016 Jun 21;44(6):1325-36. 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2030316, encodeId=8379203031692, content=<a href='/topic/show?id=25079e7287' target=_blank style='color:#2F92EE;'>#Immunity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9772, encryptionId=25079e7287, topicName=Immunity)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Sat Sep 03 09:55:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122312, encodeId=0eb0122312c0, content=己拜读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 10:00:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988502, encodeId=2181198850260, content=<a href='/topic/show?id=1637e3378a8' target=_blank style='color:#2F92EE;'>#研究员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73378, encryptionId=1637e3378a8, topicName=研究员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Fri Dec 23 06:55:00 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992199, encodeId=08131992199d9, content=<a href='/topic/show?id=482c4266209' target=_blank style='color:#2F92EE;'>#复旦中山医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42662, encryptionId=482c4266209, topicName=复旦中山医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Fri May 26 07:55:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1318219, encodeId=9f19131821983, content=<a href='/topic/show?id=685a101e4f8' target=_blank style='color:#2F92EE;'>#I型干扰素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10174, encryptionId=685a101e4f8, topicName=I型干扰素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438452, encodeId=e8c1143845223, content=<a href='/topic/show?id=aadc2211255' target=_blank style='color:#2F92EE;'>#中山医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22112, encryptionId=aadc2211255, topicName=中山医院)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538472, encodeId=2ce015384e29a, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2030316, encodeId=8379203031692, content=<a href='/topic/show?id=25079e7287' target=_blank style='color:#2F92EE;'>#Immunity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9772, encryptionId=25079e7287, topicName=Immunity)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Sat Sep 03 09:55:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122312, encodeId=0eb0122312c0, content=己拜读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 10:00:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988502, encodeId=2181198850260, content=<a href='/topic/show?id=1637e3378a8' target=_blank style='color:#2F92EE;'>#研究员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73378, encryptionId=1637e3378a8, topicName=研究员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Fri Dec 23 06:55:00 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992199, encodeId=08131992199d9, content=<a href='/topic/show?id=482c4266209' target=_blank style='color:#2F92EE;'>#复旦中山医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42662, encryptionId=482c4266209, topicName=复旦中山医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Fri May 26 07:55:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1318219, encodeId=9f19131821983, content=<a href='/topic/show?id=685a101e4f8' target=_blank style='color:#2F92EE;'>#I型干扰素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10174, encryptionId=685a101e4f8, topicName=I型干扰素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438452, encodeId=e8c1143845223, content=<a href='/topic/show?id=aadc2211255' target=_blank style='color:#2F92EE;'>#中山医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22112, encryptionId=aadc2211255, topicName=中山医院)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538472, encodeId=2ce015384e29a, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=)]
    2016-09-11 1e10c84am36(暂无匿称)

    己拜读,受益匪浅

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2030316, encodeId=8379203031692, content=<a href='/topic/show?id=25079e7287' target=_blank style='color:#2F92EE;'>#Immunity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9772, encryptionId=25079e7287, topicName=Immunity)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Sat Sep 03 09:55:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122312, encodeId=0eb0122312c0, content=己拜读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 10:00:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988502, encodeId=2181198850260, content=<a href='/topic/show?id=1637e3378a8' target=_blank style='color:#2F92EE;'>#研究员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73378, encryptionId=1637e3378a8, topicName=研究员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Fri Dec 23 06:55:00 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992199, encodeId=08131992199d9, content=<a href='/topic/show?id=482c4266209' target=_blank style='color:#2F92EE;'>#复旦中山医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42662, encryptionId=482c4266209, topicName=复旦中山医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Fri May 26 07:55:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1318219, encodeId=9f19131821983, content=<a href='/topic/show?id=685a101e4f8' target=_blank style='color:#2F92EE;'>#I型干扰素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10174, encryptionId=685a101e4f8, topicName=I型干扰素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438452, encodeId=e8c1143845223, content=<a href='/topic/show?id=aadc2211255' target=_blank style='color:#2F92EE;'>#中山医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22112, encryptionId=aadc2211255, topicName=中山医院)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538472, encodeId=2ce015384e29a, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=)]
    2016-12-23 zhmscau
  4. [GetPortalCommentsPageByObjectIdResponse(id=2030316, encodeId=8379203031692, content=<a href='/topic/show?id=25079e7287' target=_blank style='color:#2F92EE;'>#Immunity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9772, encryptionId=25079e7287, topicName=Immunity)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Sat Sep 03 09:55:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122312, encodeId=0eb0122312c0, content=己拜读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 10:00:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988502, encodeId=2181198850260, content=<a href='/topic/show?id=1637e3378a8' target=_blank style='color:#2F92EE;'>#研究员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73378, encryptionId=1637e3378a8, topicName=研究员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Fri Dec 23 06:55:00 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992199, encodeId=08131992199d9, content=<a href='/topic/show?id=482c4266209' target=_blank style='color:#2F92EE;'>#复旦中山医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42662, encryptionId=482c4266209, topicName=复旦中山医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Fri May 26 07:55:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1318219, encodeId=9f19131821983, content=<a href='/topic/show?id=685a101e4f8' target=_blank style='color:#2F92EE;'>#I型干扰素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10174, encryptionId=685a101e4f8, topicName=I型干扰素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438452, encodeId=e8c1143845223, content=<a href='/topic/show?id=aadc2211255' target=_blank style='color:#2F92EE;'>#中山医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22112, encryptionId=aadc2211255, topicName=中山医院)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538472, encodeId=2ce015384e29a, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2030316, encodeId=8379203031692, content=<a href='/topic/show?id=25079e7287' target=_blank style='color:#2F92EE;'>#Immunity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9772, encryptionId=25079e7287, topicName=Immunity)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Sat Sep 03 09:55:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122312, encodeId=0eb0122312c0, content=己拜读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 10:00:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988502, encodeId=2181198850260, content=<a href='/topic/show?id=1637e3378a8' target=_blank style='color:#2F92EE;'>#研究员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73378, encryptionId=1637e3378a8, topicName=研究员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Fri Dec 23 06:55:00 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992199, encodeId=08131992199d9, content=<a href='/topic/show?id=482c4266209' target=_blank style='color:#2F92EE;'>#复旦中山医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42662, encryptionId=482c4266209, topicName=复旦中山医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Fri May 26 07:55:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1318219, encodeId=9f19131821983, content=<a href='/topic/show?id=685a101e4f8' target=_blank style='color:#2F92EE;'>#I型干扰素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10174, encryptionId=685a101e4f8, topicName=I型干扰素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438452, encodeId=e8c1143845223, content=<a href='/topic/show?id=aadc2211255' target=_blank style='color:#2F92EE;'>#中山医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22112, encryptionId=aadc2211255, topicName=中山医院)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538472, encodeId=2ce015384e29a, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2030316, encodeId=8379203031692, content=<a href='/topic/show?id=25079e7287' target=_blank style='color:#2F92EE;'>#Immunity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9772, encryptionId=25079e7287, topicName=Immunity)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Sat Sep 03 09:55:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122312, encodeId=0eb0122312c0, content=己拜读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 10:00:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988502, encodeId=2181198850260, content=<a href='/topic/show?id=1637e3378a8' target=_blank style='color:#2F92EE;'>#研究员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73378, encryptionId=1637e3378a8, topicName=研究员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Fri Dec 23 06:55:00 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992199, encodeId=08131992199d9, content=<a href='/topic/show?id=482c4266209' target=_blank style='color:#2F92EE;'>#复旦中山医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42662, encryptionId=482c4266209, topicName=复旦中山医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Fri May 26 07:55:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1318219, encodeId=9f19131821983, content=<a href='/topic/show?id=685a101e4f8' target=_blank style='color:#2F92EE;'>#I型干扰素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10174, encryptionId=685a101e4f8, topicName=I型干扰素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438452, encodeId=e8c1143845223, content=<a href='/topic/show?id=aadc2211255' target=_blank style='color:#2F92EE;'>#中山医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22112, encryptionId=aadc2211255, topicName=中山医院)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538472, encodeId=2ce015384e29a, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2030316, encodeId=8379203031692, content=<a href='/topic/show?id=25079e7287' target=_blank style='color:#2F92EE;'>#Immunity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9772, encryptionId=25079e7287, topicName=Immunity)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Sat Sep 03 09:55:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122312, encodeId=0eb0122312c0, content=己拜读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 10:00:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988502, encodeId=2181198850260, content=<a href='/topic/show?id=1637e3378a8' target=_blank style='color:#2F92EE;'>#研究员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73378, encryptionId=1637e3378a8, topicName=研究员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Fri Dec 23 06:55:00 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992199, encodeId=08131992199d9, content=<a href='/topic/show?id=482c4266209' target=_blank style='color:#2F92EE;'>#复旦中山医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42662, encryptionId=482c4266209, topicName=复旦中山医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Fri May 26 07:55:00 CST 2017, time=2017-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1318219, encodeId=9f19131821983, content=<a href='/topic/show?id=685a101e4f8' target=_blank style='color:#2F92EE;'>#I型干扰素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10174, encryptionId=685a101e4f8, topicName=I型干扰素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438452, encodeId=e8c1143845223, content=<a href='/topic/show?id=aadc2211255' target=_blank style='color:#2F92EE;'>#中山医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22112, encryptionId=aadc2211255, topicName=中山医院)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538472, encodeId=2ce015384e29a, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Fri Jul 01 00:55:00 CST 2016, time=2016-07-01, status=1, ipAttribution=)]
    2016-07-01 saikp

相关资讯

Cell子刊:解释为何HIV不被免疫系统清除

在一项新的研究中,来自美国北卡罗来纳大学(UNC)医学院和桑福德-伯纳姆-普利贝斯医学探索研究所(Sanford Burnham Prebys Medical Discovery Institute, SBP)的研究人员鉴定出人(宿主)蛋白削弱人体对HIV和其他病毒作出的免疫反应。这一发现对改变HIV抗病毒疗法、构建有效的病毒疫苗和开发治疗癌症的新方法产生重要影响。相关研究结果发表在2016年

Ann Rheum Dis:新药Sifalimumab可改善SLE患者的症状

Sifalimumab是一种抗干扰素-α单克隆抗体,据一项新的研究表明,它或可有效治疗部分系统性红斑狼疮患者。

J Viral Hepat:纳尼?!HCV治疗失败也会增加肝癌风险?

根据最近公布的数据显示,干扰素治疗失败的丙型肝炎病毒感染患者相比达到持续病毒学应答的患者,其肝细胞癌风险更高。密歇根亨利福特卫生系统公共健康科学部的Mei Lu博士和同时对10,091名患者的数据进行了分析。数据显示,共有36%的患者接受了治疗,其中57%的患者治疗失败,43%的患者达到SVR。逆概率加权多因素和单因素分析处理后,治疗失败的患者与未治疗患者相比,HCC风险接近两倍(aHR = 1.

JCO:20年临床研究表明干扰素治疗对多数III期黑色素瘤病人无益

                         一项名为“Sunbelt Melanoma Trial”的临床研究最终结果表明,根据目前的临床诊断手段,对于大多数黑色素瘤癌症三期病人来说干扰素治疗并不会给他们带来获益。来自美国路易斯维尔大学的研究人员将相关研究结果在

Leukemia:干扰素联合达沙替尼对新诊断慢性髓系白血病有较好控制效果

最近,发表在Leukemia上的一项小型研究探讨了将聚乙二醇化干扰素ɑ2b(PegIFN)添加至酪氨酸激酶抑制剂(TKI)达沙替尼中治疗新诊断慢性髓系白血病(CML)的疗效。 研究作者说,干扰素具有强化机体抗白血病免疫反应、抑制肿瘤生长和靶向抑制白血病干细胞的作用,这不同于TKIs达沙替尼。因此,干扰素是进一步增加TKI治疗疗效的适合选择。 该研究共纳入40例新

Immunity:I型干扰素调节免疫反应机制

哺乳动物细胞能够感受环境中营养元素或氧气含量的变化,进而产生代谢上的变化。然而,最近的证据表明天然免疫细胞其模式识别受体以及细胞因子受体下游的信号也能够影响细胞的代谢反应,进而决定细胞的功能以及命运。例如。对于cDC来说,TLR的激活剂能够引发快速的糖酵解反应,从而引起葡萄糖进入TCA循环,这对于脂肪酸的合成以及DC的激活具有重要的作用。DC可以分为cDC与pDC两种类型,其中pDC主要的特点是大